Genomic Valley Biotech Ltd.
BSE: GVBL.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yogesh Agrawal
- Headquarters
- Bahadurgarh, India
- IPO year
- 2024
- Market cap
- ₹72.1M
- Website
- http://www.genomicvalley.com
Loading GVBL…
Loading profile data…Frequently asked questions about GVBL
What does Genomic Valley Biotech Ltd. (GVBL.BO) do?
Genomic Valley Biotech Ltd. operates as a development stage company. It engages in the floriculture business. The firm offers leases of ready-made greenhouses for farmers. It also researches about agriculture, stem cell, food biotechnology and environmental biotech product and process development. The company was founded on May 16, 1994 and is h...
Where does GVBL.BO trade?
Genomic Valley Biotech Ltd. (GVBL.BO) trades on the Bombay Stock Exchange.
What sector is GVBL.BO in?
Genomic Valley Biotech Ltd. (GVBL.BO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genomic Valley Biotech Ltd.?
Yogesh Agrawal is the chief executive officer of Genomic Valley Biotech Ltd. (GVBL.BO).
Where is Genomic Valley Biotech Ltd. headquartered?
Genomic Valley Biotech Ltd. is headquartered in India.
Does GVBL.BO pay a dividend?
Genomic Valley Biotech Ltd. (GVBL.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GVBL.BO go public?
Genomic Valley Biotech Ltd. (GVBL.BO) completed its initial public offering in 2024.